Compare Stocks
Compare up to four stocks to (MREO) by adding the symbol or company name.
MREO
| Compare up to three stocks to MREO by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Market Value | Market Value 446.16M | Market Value -- | Market Value -- | Market Value -- |
| Enterprise Value | EV 363.73M | EV -- | EV -- | EV -- |
| Price to Earnings | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
| Diluted Earnings Per Share | Diluted EPS TTM -0.20 | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
| Forward Dividend & Yield | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
| Sector | Sector Healthcare | Sector -- | Sector -- | Sector -- |
| Industry | Industry Biotechnology | Industry -- | Industry -- | Industry -- |
| CEO | CEO Dr. Denise Vera Scots-Knight Ph.D. | CEO -- | CEO -- | CEO -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| 1 Week | 1 Week 5.32% | 1 Week -- | 1 Week -- | 1 Week -- |
| 3 Months | 3 Months -12.67% | 3 Months -- | 3 Months -- | 3 Months -- |
| YTD | YTD 37.23% | YTD -- | YTD -- | YTD -- |
| 1 Year | 1 Year 175.65% | 1 Year -- | 1 Year -- | 1 Year -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Revenue | Revenue 10.00M | Revenue -- | Revenue -- | Revenue -- |
| Operating Expenses | Operating Expenses 34.56M | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
| Operating Income | Operating Income -27.14M | Operating Income -- | Operating Income -- | Operating Income -- |
| Revenue Growth YoY | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
| Gross Profit | Gross Profit 7.43M | Gross Profit -- | Gross Profit -- | Gross Profit -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Inventory | Inventory -- | Inventory -- | Inventory -- | Inventory -- |
| Account Receivables Turnover | A/R Turnover 6.13 | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Cash Flow from Operations | CF from Ops -21.13M | CF from Ops -- | CF from Ops -- | CF from Ops -- |
| Capital Expenditures | CapEx -419.00k | CapEx -- | CapEx -- | CapEx -- |
| Cash from Investing Activities | CFI -419.00k | CFI -- | CFI -- | CFI -- |
| Free Cash Flow | Free Cash Flow -21.55M | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Price to Earnings Per Share | P/E -- | P/E -- | P/E -- | P/E -- |
| Forward Price to Earnings Per Share | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
| Price to Free Cash Flow Per Share | P/FCF -- | P/FCF -- | P/FCF -- | P/FCF -- |
| Price to Book Value Per Share | P/BV 8.22 | P/BV -- | P/BV -- | P/BV -- |
| Price to Sales Ratio | P/S 39.04 | P/S -- | P/S -- | P/S -- |
| EV/EBITDA | EV/EBITDA -14.71 | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Operating Margin | Oper. Margin -271.36% | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
| Gross Margin | Gross Margin 74.26% | Gross Margin -- | Gross Margin -- | Gross Margin -- |
| Profit Margin | Profit Margin -294.66% | Profit Margin -- | Profit Margin -- | Profit Margin -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Basic Earnings Per Share | EPS -0.20 | EPS -- | EPS -- | EPS -- |
| EPS 1Yr Growth | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Return on Assets | Return on Assets -34.05% | Return on Assets -- | Return on Assets -- | Return on Assets -- |
| Return on Capital | Return on Capital -39.14% | Return on Capital -- | Return on Capital -- | Return on Capital -- |
| As of May 16, 2024 | MREO Mereo BioPharma Group plc | -- | -- | -- |
|---|---|---|---|---|
| Institutional Ownership % | Inst. Own. % 61.90% | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |